Investigator

Clinical research site in Chattanooga, Tennessee · Metro Service Agency, 736 Market St, Chattanooga, TN 37402 · (423) 645-7888 · Website

As of September 2026, 1 paid clinical trial is recruiting at Investigator in Chattanooga, Tennessee. Active studies at this site focus on Focal Segmental Glomerulosclerosis alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

New trial at Investigator? We'll email you when one opens.

Recruiting clinical trials at Investigator (1)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

for Focal Segmental Glomerulosclerosis

24 locations incl. Chula Vista

Sponsor: Akebia Therapeutics

Sex: All·Age: 18+

Code: NCT07268638·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

Get new-trial alerts for Investigator

We'll email you whenever a new clinical trial starts recruiting at this research site in Chattanooga, TN. Unsubscribe anytime.

More research sites in Chattanooga

Erlanger Health System (6 trials)
GSK Investigational Site (5 trials)
Southeast Renal Research Institute (5 trials)
T C Thompson Children's Hospital (5 trials)
Tennessee Oncology, PLLC - Chattanooga Downtown (4 trials)
Tennessee Oncology, PLLC - Chattanooga Med Park II (4 trials)
Tennessee Oncology, PLLC - Chattanooga Memorial (4 trials)
Erlanger Health, Inc. (3 trials)
Tennessee Oncology (3 trials)
Tennessee Oncology - Chattanooga (3 trials)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Chattanooga, TN · Tennessee clinical trials